[1]
“Imatinib mesylate in first-line treatment of chronic myeloid leukemia ”, Ann Med Res , vol. 26, no. 9, pp. 1737–1743, May 2021, Accessed: Apr. 26, 2025. [Online]. Available: http://www.annalsmedres.org/index.php/aomr/article/view/1748